Sheets Smith Wealth Management Eli Lilly & CO Transaction History

Sheets Smith Wealth Management

$807 Million
Q3 2024

A detailed history of Sheets Smith Wealth Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Sheets Smith Wealth Management holds 13,065 shares of LLY stock, worth $9.84 Million. This represents 1.43% of its overall portfolio holdings.

Number of Shares

13,065

Previous 8,794 48.57%

Holding current value

$9.84 Million

Previous $7.96 Million 45.38%

% of portfolio

1.43%

Previous 0.96%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	BUY	$772.14 - $960.02 $3.3 Million - $4.1 Million	4,271 Added 48.57%	13,065 $11.6 Million
Q2 2024 Jul 30, 2024	BUY	$724.87 - $909.04 $4.74 Million - $5.95 Million	6,541 Added 290.32%	8,794 $7.96 Million
Q1 2024 May 08, 2024	SELL	$592.2 - $792.28 $20,134 - $26,937	-34 Reduced 1.49%	2,253 $1.75 Million
Q4 2023 Feb 06, 2024	BUY	$525.19 - $619.13 $2,625 - $3,095	5 Added 0.22%	2,287 $1.33 Million
Q3 2023 Oct 23, 2023	BUY	$434.7 - $599.3 $434 - $599	1 Added 0.04%	2,282 $1.23 Million
Q2 2023 Aug 09, 2023	SELL	$350.74 - $468.98 $12,626 - $16,883	-36 Reduced 1.55%	2,281 $1.07 Million
Q1 2023 May 26, 2023	BUY	$310.63 - $364.82 $613,183 - $720,154	1,974 Added 575.51%	2,317 $795,000
Q1 2023 May 12, 2023	SELL	$310.63 - $364.82 $610,077 - $716,506	-1,964 Reduced 85.13%	343 $117,000
Q4 2022 Mar 08, 2023	SELL	$321.55 - $374.67 $38,586 - $44,960	-120 Reduced 4.94%	2,307 $843,000
Q3 2022 Nov 01, 2022	BUY	$296.48 - $337.87 $3,261 - $3,716	11 Added 0.46%	2,427 $785,000
Q2 2022 Jul 27, 2022	BUY	$278.73 - $327.27 $4,180 - $4,909	15 Added 0.62%	2,416 $783,000
Q1 2022 May 02, 2022	BUY	$234.69 - $291.66 $469 - $583	2 Added 0.08%	2,401 $688,000
Q4 2021 Jan 20, 2022	BUY	$224.85 - $279.04 $224 - $279	1 Added 0.04%	2,399 $663,000
Q2 2021 Aug 03, 2021	BUY	$180.55 - $233.54 $180 - $233	1 Added 0.04%	2,398 $550,000
Q1 2021 Apr 23, 2021	SELL	$164.32 - $212.72 $18,075 - $23,399	-110 Reduced 4.39%	2,397 $448,000
Q4 2020 Jan 13, 2021	SELL	$130.46 - $172.63 $433,909 - $574,167	-3,326 Reduced 57.02%	2,507 $423,000
Q3 2020 Oct 26, 2020	BUY	$146.22 - $169.13 $486,473 - $562,695	3,327 Added 132.76%	5,833 $863,000
Q2 2020 Jul 17, 2020	BUY	$136.42 - $164.18 $136 - $164	1 Added 0.04%	2,506 $411,000
Q4 2019 Jan 24, 2020	SELL	$106.92 - $132.43 $16,251 - $20,129	-152 Reduced 5.72%	2,505 $329,000
Q2 2019 Jul 12, 2019	BUY	$110.79 - $129.32 $110 - $129	1 Added 0.04%	2,657 $294,000
Q1 2019 May 13, 2019	SELL	$111.31 - $131.02 $27,827 - $32,755	-250 Reduced 8.6%	2,656 $345,000
Q3 2018 Oct 15, 2018	BUY	$85.86 - $107.31 $85 - $107	1 Added 0.03%	2,906 $312,000
Q1 2018 Apr 09, 2018	BUY	$74.21 - $87.6 $74 - $87	1 Added 0.03%	2,905 $225,000
Q4 2017 Jan 12, 2018	SELL	$81.94 - $87.89 $28,597 - $30,673	-349 Reduced 10.73%	2,904 $245,000
Q3 2017 Oct 12, 2017	BUY	$77.07 - $85.54 $250,708 - $278,261	3,253	3,253 $278,000

Others Institutions Holding LLY

# of Institutions

4,003

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $716B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sheets Smith Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Sheets Smith Wealth Management with notifications on news.

Account

Sheets Smith Wealth Management Eli Lilly & CO Transaction History